Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$734M |
| 2 |
Adobe
ADBE
|
+$488M |
| 3 |
Merck
MRK
|
+$443M |
| 4 |
Tesla
TSLA
|
+$366M |
| 5 |
AGN
Allergan plc
AGN
|
+$315M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$682M |
| 2 |
Perrigo
PRGO
|
+$585M |
| 3 |
Gilead Sciences
GILD
|
+$556M |
| 4 |
EMC
EMC CORPORATION
EMC
|
+$432M |
| 5 |
Morgan Stanley
MS
|
+$401M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.94% |
| 2 | Consumer Discretionary | 14.99% |
| 3 | Communication Services | 11.27% |
| 4 | Technology | 9.94% |
| 5 | Financials | 9.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
GE Aerospace
GE
$364B
| $69M | 0.07% |
513,399
+65,322
| +15% | +$8.23M |
|
252
CVS Health
CVS
$135B
| $67M | 0.07% |
936,449
-21,761
| -2% | -$1.4M |
|
|
CEB
253
DELISTED
CEB Inc.
CEB
| $66.6M | 0.07% |
860,193
-311,684
| -27% | -$22.9M |
|
|
KOG
254
DELISTED
KODIAK OIL & GAS CORP
KOG
| $66.3M | 0.07% |
5,912,559
-136,685
| -2% | -$1.64M |
|
255
Alliant Energy
LNT
$18.6B
| $66M | 0.06% |
2,558,220
| – | – |
|
|
PIR
256
DELISTED
Pier 1 Imports, Inc.
PIR
| $65.8M | 0.06% |
142,442
-18,668
| -12% | -$7.93M |
|
257
Cadence Design Systems
CDNS
$91.8B
| $65.6M | 0.06% |
4,681,382
-401,652
| -8% | -$5.39M |
|
258
Alnylam Pharmaceuticals
ALNY
$38.3B
| $65.5M | 0.06% |
1,018,156
-113,782
| -10% | -$6.79M |
|
259
Waters Corp
WAT
$37.3B
| $65.3M | 0.06% |
653,164
-5,102
| -0.8% | -$514K |
|
|
AET
260
DELISTED
Aetna Inc
AET
| $64.5M | 0.06% |
940,908
+525,768
| +127% | +$34.3M |
|
261
SM Energy
SM
$7.6B
| $64.3M | 0.06% |
773,967
+416,509
| +117% | +$35.5M |
|
262
Mattel
MAT
$4.47B
| $64.1M | 0.06% |
1,347,478
| – | – |
|
|
JCP
263
DELISTED
J.C. Penney Company, Inc.
JCP
| $63.9M | 0.06% |
6,986,114
-4,388
| -0.1% | -$36.6K |
|
|
TW
264
DELISTED
TOWERS WATSON & CO COM STK CL A (DE)
TW
| $63.9M | 0.06% |
+500,618
| New | +$58.2M |
|
265
Wendy's
WEN
$1.46B
| $63.3M | 0.06% |
7,260,308
-2,041,520
| -22% | -$17.5M |
|
266
Procter & Gamble
PG
$340B
| $63.2M | 0.06% |
776,684
| – | – |
|
267
Molina Healthcare
MOH
$10.4B
| $62.3M | 0.06% |
1,792,609
-430,580
| -19% | -$14.5M |
|
|
CERN
268
DELISTED
Cerner Corp
CERN
| $61.8M | 0.06% |
1,108,241
-6,406
| -0.6% | -$359K |
|
|
SNDK
269
DELISTED
SANDISK CORP
SNDK
| $61.6M | 0.06% |
873,916
+125,960
| +17% | +$8.49M |
|
|
WBC
270
DELISTED
WABCO HOLDINGS INC.
WBC
| $61.4M | 0.06% |
657,759
+251,856
| +62% | +$22.1M |
|
271
American Water Works
AWK
$27B
| $61.1M | 0.06% |
1,446,545
-47,647
| -3% | -$2M |
|
|
PXD
272
DELISTED
Pioneer Natural Resource Co.
PXD
| $60.6M | 0.06% |
329,076
-20,073
| -6% | -$3.87M |
|
273
Walmart Inc
WMT
$909B
| $60.6M | 0.06% |
2,308,506
-1,038,291
| -31% | -$26.8M |
|
274
Curtiss-Wright
CW
$25.1B
| $59.6M | 0.06% |
957,838
+146,503
| +18% | +$7.6M |
|
275
Thomson Reuters
TRI
$46.4B
| $59.5M | 0.06% |
1,356,130
-393,279
| -22% | -$16.8M |
|
Similar funds
Jennison Associates's Q4 2013 Portfolio in Review
As of Q4 2013, Jennison Associates held 759 positions worth $102B, up 6.9% from $95.4B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Jennison Associates's Q4 2013 filing shows 79 new, 184 increased, 411 reduced and 54 closed positions. Its largest new stake was Allergan plc: 2,016,619 shares worth $339M. The largest sale was UnitedHealth, an estimated $682M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Communication Services.
- Jennison Associates's largest Q4 2013 buy was Allergan plc: 2,016,619 shares worth $339M.
- Jennison Associates added most to Bristol-Myers Squibb in Q4 2013, an estimated $734M increase.
- Jennison Associates's biggest Q4 2013 reduction was UnitedHealth, cutting an estimated $682M.
- Jennison Associates fully exited Perrigo in Q4 2013, selling an estimated $585M.
- Jennison Associates's ten largest holdings make up 20% of its $102B portfolio in Q4 2013.
- Jennison Associates opened 79 new positions and closed 54 in Q4 2013.
- Jennison Associates's portfolio value rose 6.9% quarter-over-quarter to $102B.
Based on Jennison Associates's 13F filing for Q4 2013, filed 10 Feb 2014.